{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:50:10Z","timestamp":1789411810821,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijcard.2020.08.024","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T21:30:21Z","timestamp":1597267821000},"page":"177-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy"],"prefix":"10.1016","volume":"322","author":[{"given":"Walter B.","family":"Schiffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Deych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Lenihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijcard.2020.08.024_bb0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ijcard.2020.08.024_bb0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined Nivolumab and Ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.ijcard.2020.08.024_bb0015","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung Cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.ijcard.2020.08.024_bb0020","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.ijcard.2020.08.024_bb0025","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2020.08.024_bb0030","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.08.024_bb0035","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2019.07.079","article-title":"Cardiovascular toxicities of immune checkpoint inhibitors: JACC review topic of the week","author":"Ball","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcard.2020.08.024_bb0040","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.117.030571","article-title":"Clinical features, management, and outcomes of immune checkpoint inhibitor\u2013related Cardiotoxicity","volume":"136","author":"Escudier","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2020.08.024_bb0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaccao.2019.11.013","article-title":"Immune checkpoint inhibitor-related adverse cardiovascular events in patients with lung Cancer","volume":"1","author":"Chitturi","year":"2019","journal-title":"JACC CardioOncology"},{"issue":"13","key":"10.1016\/j.ijcard.2020.08.024_bb0050","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2020.08.024_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaccao.2019.08.005","article-title":"Incidental coronary artery calcification in Cancer imaging","volume":"1","author":"Cuddy","year":"2019","journal-title":"JACC CardioOncology"},{"issue":"2","key":"10.1016\/j.ijcard.2020.08.024_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1148\/radiol.10100383","article-title":"Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease","volume":"257","author":"Shemesh","year":"2010","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ijcard.2020.08.024_bb0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1148\/radiol.15142062","article-title":"Association of coronary artery calcification and mortality in the national lung screening trial: a comparison of three scoring methods","volume":"276","author":"Chiles","year":"2015","journal-title":"Radiology"},{"issue":"22","key":"10.1016\/j.ijcard.2020.08.024_bb0070","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1200\/JCO.19.00231","article-title":"Prospective study of cardiac events during proteasome inhibitor therapy for relapsed multiple myeloma","volume":"37","author":"Cornell","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijcard.2020.08.024_bb0075","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","author":"Ferreira","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2020.08.024_bb0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.034497","article-title":"Myocarditis in the setting of Cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology","volume":"140","author":"Bonaca","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.08.024_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01350","article-title":"Immune checkpoint inhibitor-associated cardiotoxicity: current understanding on its mechanism, diagnosis and management","author":"Zhou","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijcard.2020.08.024_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4625472","article-title":"The central role of inflammation associated with checkpoint inhibitor treatments","volume":"2018","author":"Vajaitu","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijcard.2020.08.024_bb0095","article-title":"Immunopathogenesis of immune checkpoint inhibitor-related adverse events: roles of the intestinal microbiome and Th17 cells","volume":"2254","author":"Anderson","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ijcard.2020.08.024_bb0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.08.024_bb0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2020.08.024_bb0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.ijcard.2020.08.024_bb0115","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.08.024_bb0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/JIR.S10095","article-title":"Inflammatory cytokines and atrial fibrillation:current and prospective views","author":"Hadi","year":"2010","journal-title":"J. Inflamm. Res."},{"issue":"2","key":"10.1016\/j.ijcard.2020.08.024_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2020.08.024_bb0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(96)05968-0","article-title":"Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall","volume":"127","author":"Rus","year":"1996","journal-title":"Atherosclerosis"},{"issue":"30","key":"10.1016\/j.ijcard.2020.08.024_bb0135","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1200\/JCO.19.00320","article-title":"Resumption of immune checkpoint inhibitor therapy after immune-mediated colitis","volume":"37","author":"Abu-Sbeih","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijcard.2020.08.024_bb0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/annonc\/mdx642","article-title":"Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma","volume":"29","author":"Pollack","year":"2018","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ijcard.2020.08.024_bb0145","first-page":"1","article-title":"Immune checkpoint inhibitor Rechallenge after immune-related adverse events in patients with Cancer","author":"Dolladille","year":"2020","journal-title":"JAMA Oncol"},{"issue":"25","key":"10.1016\/j.ijcard.2020.08.024_bb0150","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.18.02464","article-title":"Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: use troponin wisely","volume":"37","author":"Spallarossa","year":"2019","journal-title":"J. Clin. Oncol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320335518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320335518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:49:56Z","timestamp":1759092596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320335518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":30,"alternative-id":["S0167527320335518"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.024","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}